Professor David Nutt to Explore the Future of Medical Cannabis Research at London Symposium
Professor David Nutt has been announced as a key speaker at the Cannabis Health Symposium in London later this year.
24 results for “cbpms”
Professor David Nutt has been announced as a key speaker at the Cannabis Health Symposium in London later this year.
There remains debate within policing over how prescribed medical cannabis patients should be dealt with safely at the roadside.
In the eight years since, the NHS has issued just five prescriptions for unlicenced specials cannabis medicines, creating a two-tier system with access only to those who can afford to pay for it.
Devon Partnership NHS Trust has approved procedures for patients to continue taking their prescribed cannabis-based medications while in hospital.
Introducing The Medical Cannabis Employer Handbook
The party has passed a motion that aims to protect patients from discrimination related to their use of prescribed cannabis medicines.
A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
By Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf […]
Last week, the first official guidance on medical cannabis for police officers in England and Wales was made public.
The team at Prohibition Partners shares how they think things will shape up for medical cannabis in 2026.
In the first of a series of deep dives in the UK market, we look into its rapid growth, the shift in dominance of popular strains, and the dramatic swing towards higher THC products.
The authors say the guidance aims to address “clear gaps” in prescriber training and education.
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the […]
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium. The event embodied the UK medical cannabis industry’s […]
A quick rundown of the highlights so far, and what’s still left to look forward to.
From endometriosis and chronic pelvic pain to PMDD and menopause, more women are turning to cannabis-based medicine, but what do we know and where do we still need more research? […]
What was once hailed as a historic victory has become a ‘national failure’, campaigners say.
We unpack the science behind the ECS and its significance in a range of chronic conditions.
Healthcare professionals attending the Cannabis Health Symposium next month will be able to earn CPD points to support their professional development. The Cannabis Health Symposium is a Continuing Professional Development […]
Almost seven years since medical cannabis was legalised in the UK on 1st November 2018, less than 1% of the UK’s approximate 100,000 doctors on the General Medical Council (GMC) […]
We examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry.
Curaleaf Laboratories’ sponsorship forms part of its ongoing collaboration with the MCCS.
A new report from the General Pharmaceutical Council’s (GPhC) provides the most detailed regulatory snapshot yet of how medical cannabis is being dispensed across the UK.
A number of studies have explored whether medicinal cannabis could be used to treat some of the common symptoms.